The National Alliance for Recovery Residences published this guide to supporting the use of medication assisted treatment (MAT) in recovery housing programs in 2019. Directed at state and local policy makers, the report describes the challenges of adding MAT to recovery residence programs and proposes strategies for expanding recovery housing overall and specifically housing programs that can support residents on MAT.
Medications for Opioid Use Disorder Save Lives: Consensus Study Report – Highlights
Source: National Academies of Science, Engineering, and Medicine
This four page document presents the highlights from the 2019 National Academies report on medication assisted treatment for opioid use disorder. Funding Source: National Institute on Drug Abuse, National Institutes of Health; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Medications for Opioid Use Disorder Save Lives: Consensus Study Report – Conclusions
Source: National Academies of Science, Engineering, and Medicine
This one page document summarizes the conclusions of the 2019 National Academies report on medications for opioid use disorder.
Extended-Release Opioid Agonists and Antagonist Medications for Addiction Treatment (MAT) in Patients with Opioid Use Disorder: Effectiveness and Value
Source: New England Comparative Effectiveness Public Advisory Council (CEPAC)
This 2018 report from the Institute for Clinical and Economic Review compared the evidence for effectiveness and value of new extended-release medications for opioid use disorder (two buprenorphine injections, one buprenorphine implant, and naltrexone injection).
State and Local Policy Levers for Increasing Treatment and Recovery Capacity to Address the Opioid Epidemic: Final Report
Source: Office of the Assistant Secretary for Planning and Evaluation (ASPE), US Department of Health and Human Services
This report provides financing strategies and workforce development strategies for state policy makers interested in expanding access to treatment for opioid use disorder, particularly medication assisted treatment.
Treatment of Opioid Use Disorder
Source: National Judicial Opioid Task Force
This report from the National Judicial Opioid Task Force provides information about medication assisted treatment (MAT) for opioid use disorder (OUD) . It includes a description of MAT medications and legal considerations about MAT.
Medication-Assisted Treatment in Drug Courts: Recommended Strategies
Source: Legal Action Center
This publication presents strategies for incorporating medication assisted treatment (MAT) into treatment courts.
Acupuncture for Chronic Pain in the Vermont Medicaid Population: A Prospective, Pragmatic Intervention Trial
Source: Robert T. Davis, et. al.
This is a 2018 journal report of a pilot project to provide acupuncture for some Vermont Medicaid patients with chronic pain diagnoses.
Medicaid Acupuncture Pilot Project Outcomes Report
Source: State of Vermont - Department of Vermont Health Access
This 2017 report to the Vermont legislature summarizes the findings of a pilot study of providing acupuncture to Medicaid patients with chronic pain.
Evidence-based Nonpharmacologic Strategies for Comprehensive Pain Care: The Consortium Pain Task Force White Paper
Source: The Pain Task Force of the Academic Consortium for Integrative Medicine and Health
A 2017 white paper from the Academic Consortium for Integrative Medicine and Health, section one of this report reviews the current status of medical pain management and the nature of the pain crisis in America.